NBRVX | VMVAX | NBRVX / VMVAX | |
Total Expense Ratio | 1.50 | 0.07 | 2,143% |
Annual Report Gross Expense Ratio | 1.53 | 0.07 | 2,186% |
Fund Existence | 26 years | 14 years | - |
Gain YTD | 6.657 | 6.714 | 99% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 52.4M | 32B | 0% |
Annual Yield % from dividends | 0.59 | 2.15 | 27% |
Returns for 1 year | 5.53 | 4.45 | 124% |
Returns for 3 years | 21.78 | 30.22 | 72% |
Returns for 5 years | 79.20 | 66.70 | 119% |
Returns for 10 years | 40.46 | 102.84 | 39% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BMPEX | 28.72 | 0.10 | +0.35% |
Beck Mack + Oliver Partners | |||
PMFJX | 22.14 | N/A | N/A |
Principal MidCap S&P 400 Index J | |||
EQIDX | 14.30 | N/A | N/A |
Allspring Emerging Markets Eq Advtg Adm | |||
TBWIX | 21.87 | -0.01 | -0.05% |
Thornburg Better World International I | |||
JACNX | 30.79 | -0.05 | -0.16% |
Janus Henderson Contrarian D |